Search research articles
Contact Us
Filters
Showing results (51-60 of 102) with videos related to
Page
of 11
Sort By:
Seminars in Arthritis and Rheumatism
|
November 7, 2018
Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis
Brigitte Bader-Meunier, Roman Krzysiek, Irène Lemelle, et al.
Rheumatology (Oxford, England)
|
January 24, 2020
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology
Cyril Gitiaux, Vincent Bondet, Nassima Bekaddour, et al.
Rheumatology (Oxford, England)
|
February 24, 2018
Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis
Jessie Aouizerate, Marie De Antonio, Brigitte Bader-Meunier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 14, 2020
From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies
Cyrielle Hou, Chloé Durrleman, Baptiste Periou, et al.
Rheumatology (Oxford, England)
|
March 18, 2024
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients
Huong D Nguyen, Fabienne Jouen, Benoit Déchelotte, et al.
La Revue De Medecine Interne
|
June 21, 2025
French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease
Pierre Quartier, Alexandre Belot, Sylvain Breton, et al.
Musculoskeletal Care
|
March 10, 2023
Factors associated with poor prognosis of hip arthritis in juvenile idiopathic arthritis: Data from the JIR cohort
Wafa Hamdi, Hanene Ferjani, Raffaella Carlomagno, et al.
The Lancet. Child & Adolescent Health
|
July 6, 2020
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis
Naim Ouldali, Marie Pouletty, Patricia Mariani, et al.
Pediatric Research
|
June 11, 2026
Type I interferon signature does not correlate with disease activity in Blau syndrome
Benjamin Fournier, Héloïse Reumaux, Isabelle Melki, et al.
Rheumatology (Oxford, England)
|
February 12, 2021
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study
Tom Le Voyer, Cyril Gitiaux, François-Jérôme Authier, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 102) with videos related to
Sort By:
Page
of 11
Seminars in Arthritis and Rheumatism
|
November 7, 2018
Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis
Brigitte Bader-Meunier, Roman Krzysiek, Irène Lemelle, et al.
Rheumatology (Oxford, England)
|
January 24, 2020
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology
Cyril Gitiaux, Vincent Bondet, Nassima Bekaddour, et al.
Rheumatology (Oxford, England)
|
February 24, 2018
Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis
Jessie Aouizerate, Marie De Antonio, Brigitte Bader-Meunier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 14, 2020
From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies
Cyrielle Hou, Chloé Durrleman, Baptiste Periou, et al.
Rheumatology (Oxford, England)
|
March 18, 2024
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients
Huong D Nguyen, Fabienne Jouen, Benoit Déchelotte, et al.
La Revue De Medecine Interne
|
June 21, 2025
French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease
Pierre Quartier, Alexandre Belot, Sylvain Breton, et al.
Musculoskeletal Care
|
March 10, 2023
Factors associated with poor prognosis of hip arthritis in juvenile idiopathic arthritis: Data from the JIR cohort
Wafa Hamdi, Hanene Ferjani, Raffaella Carlomagno, et al.
The Lancet. Child & Adolescent Health
|
July 6, 2020
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis
Naim Ouldali, Marie Pouletty, Patricia Mariani, et al.
Pediatric Research
|
June 11, 2026
Type I interferon signature does not correlate with disease activity in Blau syndrome
Benjamin Fournier, Héloïse Reumaux, Isabelle Melki, et al.
Rheumatology (Oxford, England)
|
February 12, 2021
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study
Tom Le Voyer, Cyril Gitiaux, François-Jérôme Authier, et al.
Page
of 11